Health Board team contributeS to breakthrough COVID19 treatment
Staff at Queen Elizabeth University Hospital, Glasgow Royal Infirmary, Royal Alexandra Hospital and Inverclyde Royal Hospital.
By Democrat reporter
NHS Greater Glasgow and Clyde clinicians, researchers and patients have contributed to the breakthrough discovery of an effective treatment of COVID-19.
A low dose steroid, dexamethasone, should become standard of care for hospitalised patients with COVID-19 receiving oxygenation or ventilation.
Staff at Queen Elizabeth University Hospital, Glasgow Royal Infirmary, Royal Alexandra Hospital and Inverclyde Royal Hospital have been a part of the UK-wide RECOVERY trial that has made this discovery.
Over 230 NHSGGC patients have been part of the trial that has been testing pre-existing medicine such as steroids, antivirals and antimalarial agents.
This is one of several clinical trials NHS Greater Glasgow and Clyde is taking part in, as part of our overall multidisciplinary team Research and Development’s response to COVID-19.